Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study

Muratori, Paolo; Efe, Cumali; Muratori, Luigi; Ozaslan, Ersan; Schiano, Thomas; Yoshida, Eric; Heurgue-Berlot, Alexandra; Lalanne, Claudine; Lenzi, Marco; Wahlin, Staffan

doi:10.1097/meg.0000000000000870

Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study

Muratori P., Efe C., Muratori L., Ozaslan E., Schiano T., Yoshida E. M., ...Daha Fazla

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.29, sa.7, ss.777-780, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29 Sayı: 7
Basım Tarihi: 2017
Doi Numarası: 10.1097/meg.0000000000000870
Dergi Adı: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.777-780
Hacettepe Üniversitesi Adresli: Evet

Özet

Background/aim Antimitochondrial antibody (AMA) positivity is the serological marker of primary biliary cholangitis (PBC), but can also be sporadically detected in autoimmune hepatitis (AIH). Little is known about the clinical significance of AMA in AIH.